NEW YORK (GenomeWeb) – At the American Association of Clinical Chemistry meeting last week, UK-based engineering consultancy TTP launched a development service based around a pre-developed rapid molecular diagnostic platform and disposables.

The firm will now market the system to assay developers wishing to enter the point-of-care, or "point-of-clinic," market with their own tests on an OEM platform.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.